Cargando…
Heart Failure Pharmacological Management: Gaps and Current Perspectives
Proper therapeutic management of patients with heart failure (HF) is a major challenge for cardiologists. Current guidelines indicate to start therapy with angiotensin converting enzyme inhibitors/angiotensin receptor neprilysin inhibitors (ACEi/ARNI), beta blockers (BB), mineralocorticoid receptor...
Autores principales: | Severino, Paolo, D’Amato, Andrea, Prosperi, Silvia, Myftari, Vincenzo, Canuti, Elena Sofia, Labbro Francia, Aurora, Cestiè, Claudia, Maestrini, Viviana, Lavalle, Carlo, Badagliacca, Roberto, Mancone, Massimo, Vizza, Carmine Dario, Fedele, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917449/ https://www.ncbi.nlm.nih.gov/pubmed/36769667 http://dx.doi.org/10.3390/jcm12031020 |
Ejemplares similares
-
Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients
por: Severino, Paolo, et al.
Publicado: (2023) -
The Mutual Relationship among Cardiovascular Diseases and COVID-19: Focus on Micronutrients Imbalance
por: Severino, Paolo, et al.
Publicado: (2022) -
Protection against Ischemic Heart Disease: A Joint Role for eNOS and the K(ATP) Channel
por: Severino, Paolo, et al.
Publicado: (2023) -
Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility
por: Severino, Paolo, et al.
Publicado: (2023) -
Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View
por: Prosperi, Silvia, et al.
Publicado: (2023)